health tech2 min read
Biotech now sells pet cloning and cryonics, MIT Technology Review finds
Pet owners who cannot face losing an animal now have a growing menu of biotech options. They range from longevity drugs to cloning and cryonics. MIT Technology Review laid out the options this week, and questioned whether some of them are wise.
By Darius PopaThe Next Web AI

Read the full story
Originally published by The Next Web AI on Oct 18, 2026.
Comments
Sign in to join the discussion.